BioMarin Pharmaceutical, Inc. (NASDAQ:BMRN)

CAPS Rating: 3 out of 5

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.

Recs

0
Player Avatar usubanas (99.50) Submitted: 6/28/2012 2:21:19 PM : Outperform Start Price: $37.26 BMRN Score: +11.50

takeout target

Report this Post Reply

Featured Broker Partners


Advertisement